Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study

OBJECTIVE: To evaluate the efficacy and safety of neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma (ESCC). METHODS: The data of thirty-one patients with locally advanced ESCC (cT1-2N+M0, cT3-4aNanyM0) recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Li, Yong, Xue, Liyan, Qu, Dong, Jiang, Zhichao, Wang, Zhen, Yang, Zhaoyang, Zhou, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936675/
https://www.ncbi.nlm.nih.gov/pubmed/33688259
http://dx.doi.org/10.2147/CMAR.S298360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936675/
https://www.ncbi.nlm.nih.gov/pubmed/33688259
http://dx.doi.org/10.2147/CMAR.S298360

Ejemplares similares